Technical Analysis for CMPS - COMPASS Pathways Plc

Grade Last Price % Change Price Change
D 30.675 -5.24% -1.70
CMPS closed up 0.37 percent on Monday, September 27, 2021, on 77 percent of normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical CMPS trend table...

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction -5.24%
20 DMA Resistance Bearish -4.88%
Shooting Star Candlestick Bearish -4.88%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -4.88%
Bollinger Band Squeeze Range Contraction -4.88%
Doji - Bearish? Reversal -4.88%
20 DMA Resistance Bearish -5.96%
Bollinger Band Squeeze Range Contraction -5.96%
NR7 Range Contraction -5.96%
Up 3 Days in a Row Strength -5.96%
Older End-of-Day Signals for CMPS ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 5% about 4 hours ago
60 Minute Opening Range Breakdown about 4 hours ago
Down 1 ATR about 5 hours ago
2x Volume Pace about 5 hours ago
1.5x Volume Pace about 5 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

COMPASS Pathways Plc Description

COMPASS Pathways plc is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Our focus is on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. We are pioneering the development of a new model of psilocybin therapy, in which our proprietary formulation of synthetic psilocybin, COMP360, is administered in conjunction with psychological support. COMP360 has been designated a Breakthrough Therapy by the US Food and Drug Administration (FDA), for treatment-resistant depression (TRD), and we are currently conducting a phase IIb clinical trial of psilocybin therapy for TRD, in 20 sites across Europe and North America. We are headquartered in London, UK, with offices in New York, USA. Our vision is a world of mental wellbeing.


Classification

Sector: Other
Industry: Other
Keywords: Health Sciences Drug Discovery Psychoactive Drugs Mental Health FDA Entheogens Major Depressive Disorder Depression Breakthrough Therapy MP3 Treatment Resistant Depression

Is CMPS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 61.69
52 Week Low 29.31
Average Volume 318,658
200-Day Moving Average 39.00
50-Day Moving Average 33.20
20-Day Moving Average 32.94
10-Day Moving Average 32.34
Average True Range 1.40
ADX 11.53
+DI 18.69
-DI 23.64
Chandelier Exit (Long, 3 ATRs) 31.30
Chandelier Exit (Short, 3 ATRs) 35.06
Upper Bollinger Bands 34.62
Lower Bollinger Band 31.27
Percent B (%b) 0.33
BandWidth 10.14
MACD Line -0.21
MACD Signal Line -0.17
MACD Histogram -0.0465
Fundamentals Value
Market Cap 1.13 Billion
Num Shares 34.8 Million
EPS
Price-to-Sales 0.00
Price-to-Book 7.89
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 34.10
Resistance 3 (R3) 33.94 33.20 33.81
Resistance 2 (R2) 33.20 32.76 33.28 33.71
Resistance 1 (R1) 32.79 32.49 33.00 32.95 33.62
Pivot Point 32.05 32.05 32.16 32.13 32.05
Support 1 (S1) 31.64 31.61 31.85 31.80 31.12
Support 2 (S2) 30.90 31.34 30.98 31.03
Support 3 (S3) 30.49 30.90 30.93
Support 4 (S4) 30.65